On 2026-08-13, Parabilis Medicines, Inc. (PBLS) announced earnings per share of $-2.13 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.16.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-13 | 2026-06-30 | $-0.16 | $-2.13 |